Early Stage Drug Development Company
We’re development of Organ On-Chip System to which real human blood is applied
and drug application efficacy test and evaluation company
Introduction & Strategy
(Human) Organ On-chip Monitoring System
| item | Existing Micro On Chip Products | Development Macro On Chip Product |
|---|---|---|
| size of blood vessels in the chip | 0.5~1mm | 3~10mm |
| Application reagent | Serum or Media | Media, Serum, Blood |
| Test environment | Normal | Sterilization |
| Gas | None | Air &CO2 |
| Use | Biotechnology laboratory | Medical laboratory |
| Blood pressure and Blood flow | Non-adjustable | Adjustable |
| Test time Span | 5 min. | 4 Hour |
| Test Coverage | Efficacy Evaluation | Causes of pathology, efficacy, stability, side effects |
| Base cell | organ cells or iPS | organ cells, iPS or Fibroblast |
| Chip Production Cost | USD about $1,500 | USD about $3,000 |
| System Estimated Price | None | USD 1 million |
Technology introduction
- Microenvironment type
- Vessel contraction and relaxation conduction measurements (FSS and CS)
- Induced pluripotent stem cells (iPSc) applied to venous endothelial cells (HUVEC) and other organ cells Serum or drug mixture media application
- Separate operating system for each devic
- On-chip system for actual blood application
- Vessel On-Chip Device of actual blood vessel size
- Blood pressure and blood flow control/blood GAS control for FSS and CS
- Aseptic environmental conditions / temperature control (35~45℃)
- PC-based online control system
Vessel On-Chip
Fibroblast cell
Vessel On-Chip Test Coverage
Certificate & Press release
- KC certification mark
(electromagnetic compatibility registration)
- Press release [Hansbiz]
- Press release [Hankook Ilbo]
